The efficacy-toxicity conundrum: breaking the mold.
Publication
, Journal Article
Diehl, LF
Published in: Blood
March 5, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
March 5, 2020
Volume
135
Issue
10
Start / End Page
704 / 706
Location
United States
Related Subject Headings
- Lymphadenopathy
- Immunology
- Humans
- Hodgkin Disease
- Fungi
- Brentuximab Vedotin
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Diehl, L. F. (2020). The efficacy-toxicity conundrum: breaking the mold. Blood, 135(10), 704–706. https://doi.org/10.1182/blood.2019004464
Diehl, Louis F. “The efficacy-toxicity conundrum: breaking the mold.” Blood 135, no. 10 (March 5, 2020): 704–6. https://doi.org/10.1182/blood.2019004464.
Diehl LF. The efficacy-toxicity conundrum: breaking the mold. Blood. 2020 Mar 5;135(10):704–6.
Diehl, Louis F. “The efficacy-toxicity conundrum: breaking the mold.” Blood, vol. 135, no. 10, Mar. 2020, pp. 704–06. Pubmed, doi:10.1182/blood.2019004464.
Diehl LF. The efficacy-toxicity conundrum: breaking the mold. Blood. 2020 Mar 5;135(10):704–706.
Published In
Blood
DOI
EISSN
1528-0020
Publication Date
March 5, 2020
Volume
135
Issue
10
Start / End Page
704 / 706
Location
United States
Related Subject Headings
- Lymphadenopathy
- Immunology
- Humans
- Hodgkin Disease
- Fungi
- Brentuximab Vedotin
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine